May. 15 at 8:46 PM
$ALLR Cash Position: As of March 31, 2026, cash and restricted cash totaled
$29.8 million, compared to total cash and restricted cash of
$27.7 million at March 31, 2025.
Prepaid Expenses: Prepaid expenses increased to
$3.5 million at March 31, 2026, compared to
$2.1 million at December 31, 2025, primarily reflecting payments related to stenoparib API manufacturing activities supporting potential pivotal-stage development.
OS count is 15m
